logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Homozygous Familial Hypercholesterolemia

    FiltersReset Filters
    19 results

    • atorvastatin calcium

      (ATORVASTATIN CALCIUM)
      NorthStar RxLLC
      Usage: Atorvastatin calcium tablets are indicated to reduce the risk of cardiovascular events in adults with multiple risk factors or established coronary heart disease, and to lower LDL cholesterol in patients with various forms of hyperlipidemia, including primary hyperlipidemia and familial hypercholesterolemia, in adults and children 10 years and older.

    • atorvastatin calcium

      (ATORVASTATIN CALCIUM)
      Camber Pharmaceuticals, Inc.
      Usage: Atorvastatin calcium tablets are indicated for reducing cardiovascular risks in adults and managing cholesterol levels, including primary hyperlipidemia, heterozygous and homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and hypertriglyceridemia, as well as in patients with diabetes and multiple coronary heart disease risk factors.

    • atorvastatin calcium

      (Atorvastatin Calcium)
      Lupin Pharmaceuticals Inc
      Usage: Atorvastatin calcium is indicated for reducing the risk of myocardial infarction, stroke, and related procedures in adults with risk factors for coronary heart disease, and for lowering LDL cholesterol in patients with hyperlipidemia, familial hypercholesterolemia, and other lipid disorders as an adjunct to diet.

    • atorvastatin calcium

      (Atorvastatin Calcium)
      Teva Pharmaceuticals USA, Inc.
      Usage: Atorvastatin calcium is indicated to reduce the risk of heart-related events in adults with risk factors for coronary heart disease and to lower LDL cholesterol levels in adults and pediatric patients with various forms of hyperlipidemia, including familial hypercholesterolemia and dysbetalipoproteinemia.

    • atorvastatin calcium

      (atorvastatin calcium, film coated)
      Rising Pharma Holdings, Inc.
      Usage: Atorvastatin calcium is indicated to reduce the risk of heart-related issues in adults with multiple risk factors for coronary heart disease and those with type 2 diabetes. It also lowers LDL cholesterol in patients with primary hyperlipidemia, familial hypercholesterolemia, and other lipid disorders.

    • evkeeza

      (evinacumab)
      Regeneron Pharmaceuticals, Inc.
      Usage: EVKEEZA is indicated as an adjunct therapy for adult and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness in other types of hypercholesterolemia, such as heterozygous familial hypercholesterolemia, have not been established.

    • ezallor sprinkle

      (ROSUVASTATIN)
      Sun Pharmaceutical Industries, Inc.
      Usage: EZALLOR SPRINKLE is indicated to reduce the risk of major adverse cardiovascular events in at-risk adults, lower LDL cholesterol in various hyperlipidemia types, and treat primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It can be used alone or with other LDL-lowering therapies for patients with familial hypercholesterolemia.

    • ezetimibe

      (Ezetimibe)
      Orient Pharma Co., Ltd.
      Usage: Ezetimibe is indicated for reducing elevated LDL-C in adults and pediatric patients with primary hyperlipidemia, including HeFH and HoFH, as well as in mixed hyperlipidemia. It also helps decrease elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia, as an adjunct to diet.

    • ezetimibe and simvastatin

      (Ezetimibe and Simvastatin)
      AvKARE
      Usage: Ezetimibe and simvastatin are indicated for reducing cholesterol levels in patients with primary or mixed hyperlipidemia and for treating homozygous familial hypercholesterolemia as an adjunct to other therapies. These medications are part of a broader strategy to manage atherosclerotic vascular disease risk due to hypercholesterolemia.

    • juxtapid

      (lomitapide mesylate)
      Amryt Pharmaceuticals DAC
      Usage: JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments to reduce LDL-C, total cholesterol, apo B, and non-HDL-C in patients with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness are not established for other types of hypercholesterolemia.